-
PRINCETON, NJ, US - Oct 15, 2018 - Certara®, the global leader in model-informed drug development, regulatory science, market access and real-world evidence solutions, today announced that it has formed a strategic collaboration with Hedera Hashgraph
Oct 15, 2018
-
PRINCETON, NJ, US - Oct 11, 2018 - WIRB-Copernicus Group® (WCG), the worlds leading provider of solutions that measurably improve the quality and efficiency of clinical research, today announced that one of its thought leaders will lead a human gene transfer educational course at the American Biological Safety Association (ABSA) 61st Annual Biological Safety Conference
Oct 12, 2018
-
SUFFERN, CA, UNITED STATES - Oct 8, 2018 - SUFFERN, N.Y., Oct. 08, 2018 (GLOBE NEWSWIRE) -- CDx Diagnostics, an innovator in computer-synthesized, three dimensional tissue analysis for the early detection and surveillance of Barretts esophagus, today announced new data for WATS3D, or Wide Area Transepithelial Sampling with 3D Tissue Analysis, demonstrating the clinical significance of crypt dysplasia as an important risk factor for progression to high-grade esophageal dysplasia or esophageal cancer
Oct 11, 2018
-
CRAIGAVON, NORTHERN IRELAND - Oct 11, 2018 - Almac Diagnostic Services, a global stratified medicine company specialising in biomarker driven clinical trials, has made a significant investment in a new Illumina NovaSeq 6000 sequencer which will benefit Biopharma clients biomarker discovery and clinical trial projects
Oct 10, 2018
-
BETHESDA, MD, US - Oct 9, 2018 - The International Biomedical Research Alliance, a non-profit organization which provides programming and funding support for the National Institutes of Health (NIH) Oxford-Cambridge Scholars Program, today announced that Ralph A
Oct 9, 2018
-
PRINCETON, NJ, US - Oct 9, 2018 - Certara®, the global leader in model-informed drug development, regulatory science, market access and real-world evidence solutions, today announced that the US Food and Drug Administration (FDA) has renewed, and in many cases increased, its number of Certara software licenses for reviewing new drug and biologics applications
Oct 9, 2018
-
HEIDELBERG, BOSTON, GERMANY - Oct 9, 2018 -
Hummingbird Diagnostics GmbH today announced that Prof. Dr. med. Jörg Debatin is appointed Chairman of the Supervisory Board with immediate effect
Oct 9, 2018
-
WESTBURY, NY, US - Oct 8, 2018 - BioIVT, a leading provider of research models and services for drug development, today announced that it has acquired Clinical Trials Laboratory Services (CTLS), a donor center and laboratory based in London, UK
Oct 8, 2018
-
PRINCETON, NJ, US - Oct 5, 2018 - Certara®, the global leader in model-informed drug development, regulatory science, market access and real-world evidence solutions, today announced that it is participating in 40 sessions at the ninth American Conference on Pharmacometrics (ACoP9)
Oct 5, 2018
-
BOSTON, MA, UNITED STATES - Sep 28, 2018 - UgenTec today announced a new end-point PCR analysis software called FastTyper. FastTyper uses artificial intelligence (AI) methods to significantly accelerate genotyping analysis workflows and improve data interpretation in applications such as agricultural breeding programs
Sep 28, 2018
-
CARLSBAD, CA, UNITED STATES - Sep 18, 2018 - Thermo Fisher Scientific, Inc., the world leader in serving science, has licensed CRISPR technologies from the Broad Institute and ERS Genomics (foundational University of California IP) to bolster its genome editing intellectual property (IP) portfolio
Sep 26, 2018
-
PRINCETON, NJ, US - Sep 26, 2018 - Certara®, the global leader in model-informed drug development, regulatory science, market access and real-world evidence solutions, announced today the launch of its BaseCase Portal cloud-based platform, that allows for the rapid creation of fully-customizable mobile apps that connect live to mathematical models and algorithms, and help HCPs optimize treatment for individual patients
Sep 26, 2018
-
WESTBURY, NY, US - Sep 24, 2018 - BioIVT, a leading provider of research models and services for drug development, today announced that it will be hosting the 2018 HEPATOPAC User Group Meeting (UGM) from 8:30 a
Sep 24, 2018
-
OXFORD, UNITED KINGDOM - Sep 21, 2018 - An analysis of clinical data shedding light on the frequency of blood test requests from primary care reveals the potential for diagnostic platforms that combine several commonly-requested tests onto multiplex panels and could move blood testing from laboratory settings into the community
Sep 21, 2018
-
HAYWOOD, CA, UNITED STATES - Sep 20, 2018 - Paragon Genomics, Inc. today announced the launch of ParagonDesigner, its web-based tool that enables rapid design of CleanPlex® Custom NGS Panels
Sep 20, 2018
-
SYDNEY, AUSTRALIA - Sep 19, 2018 - The overuse and misuse of antibiotics has allowed the development of antibiotic-resistant bacteria.In particular the emergence of carbapenem resistance in bacteria is a major public health concern because these agents are regarded as one of the last effective therapies available for treating serious infections
Sep 18, 2018
-
NEWCASTLE, UK - Sep 14, 2018 - QuantuMDx Group Ltd, the UK-based multinational molecular diagnostics company, today announced two key leadership appointments
Sep 14, 2018
-
PRINCETON, NJ, US - Sep 13, 2018 - Certara®, the global leader in model-informed drug development, regulatory science, market access and real-world evidence solutions, announced today that it has acquired Pirana, a widely used product for connecting and organizing pharmacometric modeling results as well as providing interfaces to a range of software tools used in pharmacometrics modeling
Sep 13, 2018
-
GUILDFORD, UNITED KINGDOM - Sep 12, 2018 - Founder and Chairman, Dr David Taylor, of Guildford based MR Solutions has been shortlisted as an Innovation Entrepreneur of the Year for London and the South East in the 2018 NatWest Great British Entrepreneur Awards
Sep 12, 2018
-
WESTBURY, NY, US - Sep 10, 2018 - BioIVT, a leading provider of research models and services for drug development, today announced its research into the mechanisms involved in cholestatic drug-induced liver injury (DILI) has been published in
Applied In Vitro Toxicology
Sep 10, 2018